Stop TB Partnership calls for Urgent Action on Antimicrobial Resistance at the United Nations in New York
The Stop TB Partnership has joined with Every Women Every Child, the Review on Antimicrobial Resistance, the UN Permanent Missions of UK, South Africa, Sweden, and others to convene member states at the United Nations in New York to advance action on Antimicrobial Resistance.
Held on Monday, 15th June, the event, ‘Antimicrobial
Resistance: An Emerging Global Threat’, was co-sponsored
by a diverse group of countries including the United Kingdom,
Ethiopia, Sweden, and the UN Foreign Policy and Global Health
group comprised of France, Thailand, Senegal, Norway, Brazil,
South Africa, and Indonesia. The event comes a week after the G7
Group of Counties highlighted Antimicrobial Resistance (AMR) as
a top priority for action on the global development agenda.
The
global burden of infections resistant to existing antimicrobial
medicines is growing at an alarming pace. Drug-resistant
infections are already responsible for more than half a million
deaths globally each year and could kill an extra 10 million
people across the world annually by 2050, of which 2.5 million
could be from drug-resistant tuberculosis according to the AMR
Review’s estimates.
Addressing member
states and guests, Lord Jim O’Neill, renowned economist
and Chairman of the independent Review on AMR convened by the
Prime Minister of the United Kingdom, said “By 2050 AMR
infections will cost the world $100 trillion in lost economic
output and kill more people than cancer if we do not take
action. No new classes of antibiotics have been created for
decades and our current drugs are becoming less effective as
resistance increases. This is why we are calling for a global
innovation fund of $2 billion dollars to fund the risky,
expensive early stages of drug research.”
The
event was also addressed by Dr. Joanne Carter, Vice Chair of the
Stop TB Partnership Coordinating Board and Executive Director of
RESULTS. “It was nearly two decades ago that
drug-resistant TB was first characterized as ‘Ebola with
Wings’. The AMR Review’s findings have brought to
light the potentially massive scale and devastating impact of
drug-resistant TB and other AMR infections in both human and
economic terms. Decades of progress will be undone and the
billions invested in the Global Fund to Fight AIDS, TB and
Malaria and by national governments will be under threat unless
we address this challenge now.”
The Stop TB
Partnership also voiced its support for the call made by several
member states for a United Nations High-Level Meeting on AMR to
be held at UN Headquarters in New York in 2016.
Additional
details on the event can be found on the Every Women Every Child
website
here.